Prostaglandin

Type: Keyphrase
Name: Prostaglandin
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators

The present invention relates to 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives of the formula (I), wherein R1, R2 and R3 are as described in the description and their use as prostaglandin receptor modulators, most particularly as prostaglandin ... [Published Free Patents Online - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Pharmaceutical composition containing prostaglandin

An object of the present invention is to provide a stable aqueous pharmaceutical composition which suppresses degradation of prostaglandin F2α in a preparation containing prostaglandin F2α. The object was attained by formulating a prostaglandin F2α derivative ... [Published Free Patents Online - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Association of lipocalin-type prostaglandin D synthase with disproportionately enlarged ...

Idiopathic normal pressure hydrocephalus (iNPH) is a treatable cause of dementia, gait disturbance, and urinary incontinence in elderly patients with ventriculomegaly. Its unique morphological feature, called disproportionately enlarged subarachnoid-space ... [Published 7thSpace - Apr 15 2014]
First reported Apr 06 2014 - Updated Apr 06 2014 - 1 reports

GRC 27864 For Chronic Inflammatory Disease Enters Human Clinical Trials

Glenmark Pharmaceuticals has announced that GRC 27864 is entering human trials. GRC 27864 targets Microsomal Prostaglandin E synthase-1 (mPGES-1) as a therapeutic target in pain management. Selective mPGES-1 inhibitors are expected to inhibit increased ... [Published Scientific Blogging - Medicine - Apr 06 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

New Findings in Lung Cancer Described from Kitasato University

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Oncology. According to news originating from Sagamihara, Japan, by NewsRx correspondents, research stated, "Lung cancer is the main cause of cancer-related ... [Published NewsRX - Apr 04 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 2 reports

Glenmark’s NCE GRC 27864 for chronic inflammatory diseases to take part in human trials

GRC 27864 is a potent, selective, orally bioavailable inhibitor of mPGES-1Glenmark Pharmaceuticals' Novel Chemical Entity (NCE) 'GRC 27864' is entering human trials. This NCE programme targets Microsomal Prostaglandin E synthase-1 (mPGES-1) as a novel ... [Published Express Pharma - Apr 03 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Written description for functional limitations in view of Alcon Research Ltd. v. Barr Labs

Alcon owns US 5,631,287 (‘287), of which Claim 1 recites “[a] method of enhancing the chemical stability of an aqueous composition comprising a therapeutically-effective amount of a prostaglandin, wherein the method comprises adding a chemically-stabilizing ... [Published JD Supra - Apr 01 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 4 reports

Low-dose aspirin use linked to improved colon cancer survival

Aspirin is a medication most commonly used to treat mild to moderate pain and inflammation. But new research suggests that patients who have been diagnosed with colon cancer may have better survival by taking low doses of the drug.The research team, led ... [Published Medical News Today - Apr 01 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Composition and method for promoting hair growth

The present invention provides a method and composition for promoting hair growth in a mammal which comprises a prostaglandin compound having two hetero atoms at the 15 position as an active ingredient thereof. ... [Published Free Patents Online - Apr 01 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 1 reports

5 ways to ease painful periods

It's a painful problem that affects millions of women – monthly menstrual cramps.Painful periods are very common in teens and young women. Every cycle can mean lower abdominal pain, sharp or aching pain that comes and goes, or possibly back pain. For ... [Published Omaha World-Herald - Mar 27 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Alcon Research Ltd. v. Barr Laboratories Inc. (Fed. Cir. 2014) - Barr does not infringe, Alcon's patents not invalid

In ANDA litigation between branded drug maker Alcon Research and generic drugmaker Barr Laboratories, the Federal Circuit affirmed a District Court finding of non-infringement and reversed a finding of invalidity for failure to satisfy either the enablement ... [Published JD Supra - Mar 26 2014]
First reported Mar 26 2014 - Updated Mar 26 2014 - 1 reports

Alcon Research Ltd. v. Barr Laboratories Inc. (Fed. Cir. 2014)

Barr does not infringe, Alcon's patents not invalid By Kevin E. Noonan -- In ANDA litigation between branded drug maker Alcon Research and generic drugmaker Barr Laboratories, the Federal Circuit affirmed a District Court finding of non-infringement and ... [Published Patent Docs - Mar 26 2014]

Quotes

According to the news editors, the research concluded: "Our study supports the effective utilization of PLGA based nanoparticle formulation for diclofenac."
...background information on this patent application, NewsRx editors also obtained the inventors' summary information for this patent application: "The present disclosure relates to compounds represented by the formula:"

More Content

All (84) | News (77) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (3) | Press Releases (0)
sort by: Date | Relevance
Research Conducted at East Tennessee State Univ... [Published HispanicBusiness.com - Apr 17 2014]
Patent Application Titled "Derivatives of Sulin... [Published HispanicBusiness.com - Apr 16 2014]
ASAHI GLASS : Patent Issued for EP4 Agonist [Published 4 Traders - Apr 16 2014]
Pharmaceutical composition containing prostagla... [Published Free Patents Online - Apr 15 2014]
3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carb... [Published Free Patents Online - Apr 15 2014]
Association of lipocalin-type prostaglandin D s... [Published 7thSpace - Apr 15 2014]
Woman Dies in Italy After Taking Dangerous RU 4... [Published LifeNews.com - Apr 11 2014]
VERTEX PHARMACEUTICALS : Patent Issued for Proc... [Published 4 Traders - Apr 10 2014]
Researchers Submit Patent Application, "Multipl... [Published 4 Traders - Apr 10 2014]
ALLERGAN : Patent Issued for Extended Release B... [Published 4 Traders - Apr 10 2014]
"Single Channel, Multiple Drug Delivery Device ... [Published 4 Traders - Apr 10 2014]
Patent Issued for Pharmaceutical Composition [Published 4 Traders - Apr 10 2014]
"Methods for the Treatment, the Prognostic Asse... [Published 4 Traders - Apr 10 2014]
Glenmark''s Novel Molecule ''GRC 27864'' for Ch... [Published Asian Hospital & Healthcare Management - Apr 08 2014]
Alcon Research Ltd. v. Barr Labs, Inc., 2012-13... [Published Lexology - Apr 06 2014]
GRC 27864 For Chronic Inflammatory Disease Ente... [Published Scientific Blogging - Medicine - Apr 06 2014]
Natural Body Defense, the New Supplement Improv... [Published Digital Journal - Apr 05 2014]
A Nutritional Approach to Contact Lens Success [Published Contact Lens Spectrum - Apr 05 2014]
New Findings in Lung Cancer Described from Kita... [Published NewsRX - Apr 04 2014]
New Cancer Gene Therapy Study Results Reported ... [Published NewsRX - Apr 04 2014]
Glenmark's Chronic Inflammatory Disease Drug En... [Published Drug Discovery and Development - Apr 03 2014]
Glenmark’s NCE GRC 27864 for chronic inflammato... [Published Express Pharma - Apr 03 2014]
Market reverses direction after scaling record ... [Published Business Standard India - Apr 03 2014]
Glenmark's Novel Molecule 'GRC 27864' for Chron... [Published PR Newswire India - Apr 03 2014]
Sensex snaps six-day winning streak [Published Business Standard India - Apr 03 2014]
Glenmark’s novel molecule for chronic inflammat... [Published PharmaBiz - Apr 03 2014]
Glenmark’s novel molecule ‘GRC 27864’ entering ... [Published India Infoline - Apr 03 2014]
New Cancer Gene Therapy Study Results Reported ... [Published HispanicBusiness.com - Apr 02 2014]
Study Results from Johannes Gutenberg-Universit... [Published HispanicBusiness.com - Apr 02 2014]
Exenatide induces aortic vasodilation increasin... [Published Cardiovascular Diabetology - Apr 02 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
GRC 27864 For Chronic Inflammatory Disease Ente... [Published Scientific Blogging - Medicine - Apr 06 2014]
Glenmark Pharmaceuticals has announced that GRC 27864 is entering human trials. GRC 27864 targets Microsomal Prostaglandin E synthase-1 (mPGES-1) as a therapeutic target in pain management. Selective mPGES-1 inhibitors are expected to inhibit increased ...
An Update on Water Immersion During Labor and D... [Published Science-Based Medicine - Mar 28 2014]
Science Based Medicine last covered the increasingly common practice of laboring while immersed in water, in many cases followed by delivering the baby while still submerged, a little over four years ago. In that post , Dr. Amy Tuteur focused primarily ...
Alcon Research Ltd. v. Barr Laboratories Inc. (... [Published Patent Docs - Mar 26 2014]
Barr does not infringe, Alcon's patents not invalid By Kevin E. Noonan -- In ANDA litigation between branded drug maker Alcon Research and generic drugmaker Barr Laboratories, the Federal Circuit affirmed a District Court finding of non-infringement and ...
Aspirin reduces facial flushing with BG12 [Published Multiple Sclerosis Research - Oct 25 2013]
Aspirin reduces facial flushing with BG12. #MSBlog #MSResearch "Dimethyl-fumarate, DMF or BG12 is an effective DMT. It is given orally as a twice a day dose. One of the main side effects of the drug is facial flushing that comes on shortly after taking ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.